Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iridex Corp
(NQ:
IRIX
)
1.800
UNCHANGED
Streaming Delayed Price
Updated: 2:58 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iridex Corp
< Previous
1
2
3
Next >
Iridex Comments on Changing Glaucoma Reimbursement Landscape
November 19, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Reports Third Quarter 2024 Financial Results
November 12, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights into Iridex's Upcoming Earnings
November 11, 2024
Via
Benzinga
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
November 04, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
Iridex's Earnings Outlook
March 25, 2024
Via
Benzinga
Iridex: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
Iridex Appoints Patrick Mercer as Chief Executive Officer
October 03, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Iridex Reports Second Quarter 2024 Financial Results
August 08, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Announces Convertible Note Financing
August 05, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
July 30, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024
May 14, 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 14, 2024
Via
Benzinga
Iridex Reports First Quarter 2024 Financial Results
May 14, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
May 08, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
March 26, 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024
Advances strategic review to unlock shareholder value
From
IRIDEX Corporation
Via
GlobeNewswire
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
March 20, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Corporation Receives European Patent on MicroPulse Technology
February 06, 2024
The Advanced Short Pulse Laser System
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
January 24, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
January 11, 2024
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
December 28, 2023
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
November 27, 2023
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex Reports Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
IRIDEX Corporation
Via
GlobeNewswire
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
November 13, 2023
The Company also announced plans to present at Stifel Healthcare Conference
From
IRIDEX Corporation
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.